Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Leading the Next CBD Wave-Safety and Efficacy.

Literature DB >> 31940016

Leading the Next CBD Wave-Safety and Efficacy.

Yasmin L Hurd^1,2.

Abstract

Mesh：

Substances：
Cannabidiol

Year: 2020 PMID： 31940016 DOI： 10.1001/jamapsychiatry.2019.4157

Source DB: PubMed Journal: JAMA Psychiatry ISSN： 2168-622X Impact factor: 21.596

Keyword Cloud
Cited

× No keyword cloud information.

3 in total

1. The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report .

Authors: Jahan Marcu
Journal: Dialogues Clin Neurosci Date: 2020-09 Impact factor: 5.986

2. Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis.

Authors: Christopher J Failing; Kevin F Boehnke; Meredith Riebschleger
Journal: Pediatr Rheumatol Online J Date: 2021-12-13 Impact factor: 3.054

Review 3. Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments.

Authors: Maria Jimena Salcedo-Arellano; Ana Maria Cabal-Herrera; Ruchi Harendra Punatar; Courtney Jessica Clark; Christopher Allen Romney; Randi J Hagerman
Journal: Neurotherapeutics Date: 2020-11-19 Impact factor: 7.620

3 in total

Leading the Next CBD Wave-Safety and Efficacy.

1. The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report .

2. Cannabidiol (CBD) Use among children with juvenile idiopathic arthritis.

Review 3. Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments.

1. The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report .